Botulinum Toxin Market Size and Forecast (2021-2031)

Botulinum Toxin A Segment Held Largest Share of Product Segment in Botulinum Toxin Market

According to our latest study on “Rapid Test Kits Market Forecast to 2030 – Global Analysis – by Product, Application, and End User” the market was valued at US$ 7.38 billion in 2023 and is expected to reach US$ 19.03 billion by 2031. It is estimated to register a CAGR of 12.6% from 2023 to 2031. The report highlights the key factors and trends impacting the market and focuses on prominent players and their strategies.

Botulinum toxins are neurotoxins produced by bacteria named Clostridium botulinum. After the toxin is injected into a muscle, it blocks nerve signals to the muscle, thereby blocking its contraction and reducing unwanted facial lines or features. Botulinum toxin injections such as Botox and Dysport improve the appearance by relaxing the muscles that cause wrinkles. These injections also treat migraines, hyperhidrosis, overactive bladder, and eye problems. The botulinum toxin market size is likely to surge by 2031 owing to significant growth opportunities presented by developing countries.

Healthcare providers in developing economies are focusing on introducing various advanced medical aesthetic technologies into their service portfolios. Health facilities, medical spas, and wellness centers in these countries also offer a comprehensive range of inexpensive but high-quality medical-aesthetic procedures. Patients from developed regions approach emerging countries from APAC and Latin America to undergo various aesthetic procedures. Moreover, people in these countries are willing to spend money on cosmetic and rejuvenation procedures to improve their aesthetics. Rising disposable income and changing beauty standards have led to an increase in demand for botulinum toxin and similar products in the abovementioned region. Moreover, the botulinum toxin industry is flourishing in India as people seek nonsurgical cosmetic alternatives to invasive procedures.

Further, countries in Asia Pacific and Latin America are catching up to the botulinum toxin market in Brazil, Argentina, India, and Thailand usage due to urbanization and increased healthcare spending. Rising healthcare spending in developing economies in Asia Pacific, and South & Central America enables healthcare professionals to adopt advanced technologies for performing cosmetic procedures. For instance, according to the ISAPS, in 2021 the number of non-surgical procedures in Brazil, Argentina, India and Thailand was 542,520; 158,900; 404,016; and 29,840 respectively. Thus, evolving consumer preferences, and growing awareness, developing countries offer significant opportunities for the botulinum toxin market.

AbbVie Inc., Merz Pharma, Medytox, Ipsen Pharma, Galderma, Revance Therapeutics Inc., Lanzhou Institute of Biological Products Co Ltd, Evolus Inc, Hugel Inc, and Aquavit. are among the key players operating in the global botulinum toxin market.

The report segments the global botulinum toxin market as follows:

The botulinum toxin market is segmented on the basis of product, application, and end user.

Based on product, the market is bifurcated into botulinum toxin A and botulinum toxin B. The botulinum toxin A segment held a larger market share in 2023, and it is anticipated to register a higher CAGR during 2023–2031. Botulinum toxin A injections provide a minimally invasive and promising treatment option for muscle spasms, cosmetic imperfections, and other conditions. This type is also used in treating incontinence, migraine, hyperhidrosis, and blepharospasm. Its cosmetic applications include the reduction of wrinkles and fine lines on the face, especially wrinkles in the upper areas of the face, i.e., the side corners of the eyes, forehead, and glabellar lines.

By application, the market is bifurcated into medical and aesthetic. The medical segment held the largest botulinum toxin market share in 2023 and is anticipated to register the highest CAGR of 13.3% during 2023–2031. The medical segment is further categorized into chronic migraine, muscle spasm, overreactive bladder, hyperhidrosis, and others. The market for the aesthetic segment is further divided into frown lines/glabellar, forehead lines, crow’s feet, square jaw/ masseter, and others. Botulinum toxin is a neurotoxin used to treat and manage various medical conditions, including chronic migraine, spastic disorders, cervical dystonia, and detrusor hyperactivity. Medical applications of botulinum toxin include chronic migraine, muscle spasms, overreactive bladder, and hyperhidrosis. Chronic migraine is a severely disabling neurological disorder characterized by pulsating unilateral or bilateral headaches. It is primarily described as a headache that troubles individuals for at least 15 days per month for three months. Botulinum toxin injections have also been found to be effective in treating cerebral palsy, providing patients with major relief from severe muscle contraction. Botulinum toxin A has also been studied for its effectiveness in treating chronic lower back pain.

The scope of the botulinum toxin market report covers North America (the US, Canada, and Mexico), Europe (Spain, the UK, Germany, France, Italy, and the Rest of Europe), Asia Pacific (South Korea, China, India, Japan, Australia, and the Rest of Asia Pacific), Middle East & Africa (South Africa, Saudi Arabia, the UAE, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).

In 2023, North America accounted for the largest market share. The market growth in North America can be mainly associated with the economically stable population and increasing numbers of nonsurgical or minimally invasive cosmetic procedures performed in the abovementioned countries.

o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global botulinum toxin market.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in the global botulinum toxin market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth market trends and outlook in North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America coupled with the factors driving the market, as well as those hindering it.
o Enhancing the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table 1. Botulinum Toxin Market Segmentation 27
Table 2. Nonsurgical Procedures, by Country, 2021 34
Table 3. Global Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Medical 44
Table 4. Global Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Aesthetic 45
Table 5. North America: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Product 52
Table 6. North America: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Application 52
Table 7. North America: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Medical 52
Table 8. North America: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Aesthetic 53
Table 9. North America: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by End User 53
Table 10. United States: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Product 55
Table 11. United States: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Application 55
Table 12. United States: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Medical 56
Table 13. United States: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Aesthetic 56
Table 14. United States: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by End User 56
Table 15. Canada: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Product 57
Table 16. Canada: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Application 58
Table 17. Canada: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Medical 58
Table 18. Canada: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Aesthetic 58
Table 19. Canada: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by End User 59
Table 20. Mexico: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Product 60
Table 21. Mexico: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Application 61
Table 22. Mexico: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Medical 61
Table 23. Mexico: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Aesthetic 61
Table 24. Mexico: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by End User 62
Table 25. Europe: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Product 65
Table 26. Europe: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Application 65
Table 27. Europe: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Medical 65
Table 28. Europe: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Aesthetic 66
Table 29. Europe: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by End User 66
Table 30. Germany: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Product 68
Table 31. Germany: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Application 68
Table 32. Germany: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Medical 69
Table 33. Germany: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Aesthetic 69
Table 34. Germany: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by End User 70
Table 35. United Kingdom: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Product 72
Table 36. United Kingdom: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Application 72
Table 37. United Kingdom: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Medical 72
Table 38. United Kingdom: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Aesthetic 73
Table 39. United Kingdom: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by End User 73
Table 40. France: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Product 74
Table 41. France: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Application 75
Table 42. France: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Medical 75
Table 43. France: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Aesthetic 75
Table 44. France: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by End User 76
Table 45. Italy: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Product 77
Table 46. Italy: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Application 78
Table 47. Italy: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Medical 78
Table 48. Italy: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Aesthetic 78
Table 49. Italy: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by End User 79
Table 50. Spain: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Product 80
Table 51. Spain: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Application 81
Table 52. Spain: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Medical 81
Table 53. Spain: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Aesthetic 81
Table 54. Spain: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by End User 82
Table 55. Rest of Europe: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Product 83
Table 56. Rest of Europe: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Application 84
Table 57. Rest of Europe: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Medical 84
Table 58. Rest of Europe: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Aesthetic 85
Table 59. Rest of Europe: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by End User 85
Table 60. Asia Pacific: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Product 88
Table 61. Asia Pacific: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Application 88
Table 62. Asia Pacific: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Medical 88
Table 63. Asia Pacific: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Aesthetic 89
Table 64. Asia Pacific: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by End User 89
Table 65. Japan: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Product 91
Table 66. Japan: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Application 91
Table 67. Japan: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Medical 92
Table 68. Japan: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Aesthetic 92
Table 69. Japan: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by End User 93
Table 70. China: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Product 95
Table 71. China: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Application 95
Table 72. China: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Medical 95
Table 73. China: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Aesthetic 96
Table 74. China: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by End User 96
Table 75. India: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Product 97
Table 76. India: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Application 98
Table 77. India: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Medical 98
Table 78. India: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Aesthetic 98
Table 79. India: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by End User 99
Table 80. South Korea: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Product 100
Table 81. South Korea: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Application 100
Table 82. South Korea: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Medical 101
Table 83. South Korea: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Aesthetic 101
Table 84. South Korea: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by End User 102
Table 85. Australia: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Product 103
Table 86. Australia: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Application 104
Table 87. Australia: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Medical 104
Table 88. Australia: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Aesthetic 104
Table 89. Australia: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by End User 105
Table 90. Rest of APAC: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Product 106
Table 91. Rest of APAC: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Application 107
Table 92. Rest of APAC: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Medical 107
Table 93. Rest of APAC: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Aesthetic 107
Table 94. Rest of APAC: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by End User 108
Table 95. Middle East and Africa: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Product 110
Table 96. Middle East and Africa: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Application 110
Table 97. Middle East and Africa: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Medical 111
Table 98. Middle East and Africa: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Aesthetic 111
Table 99. Middle East and Africa: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by End User 112
Table 100. Saudi Arabia: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Product 113
Table 101. Saudi Arabia: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Application 114
Table 102. Saudi Arabia: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Medical 114
Table 103. Saudi Arabia: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Aesthetic 114
Table 104. Saudi Arabia: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by End User 115
Table 105. United Arab Emirates: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Product 116
Table 106. United Arab Emirates: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Application 117
Table 107. United Arab Emirates: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Medical 117
Table 108. United Arab Emirates: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Aesthetic 118
Table 109. United Arab Emirates: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by End User 118
Table 110. South Africa: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Product 119
Table 111. South Africa: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Application 120
Table 112. South Africa: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Medical 120
Table 113. South Africa: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Aesthetic 120
Table 114. South Africa: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by End User 121
Table 115. Rest of Middle East and Africa: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Product 123
Table 116. Rest of Middle East and Africa: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Application 123
Table 117. Rest of Middle East and Africa: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Medical 123
Table 118. Rest of Middle East and Africa: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Aesthetic 124
Table 119. Rest of Middle East and Africa: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by End User 124
Table 120. South and Central America: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Product 126
Table 121. South and Central America: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Application 126
Table 122. South and Central America: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Medical 127
Table 123. South and Central America: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Aesthetic 127
Table 124. South and Central America: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by End User 128
Table 125. South and Central America: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Country 128
Table 126. Brazil: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Product 130
Table 127. Brazil: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Application 130
Table 128. Brazil: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Medical 130
Table 129. Brazil: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Aesthetic 131
Table 130. Brazil: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by End User 131
Table 131. Argentina: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Product 132
Table 132. Argentina: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Application 133
Table 133. Argentina: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Medical 133
Table 134. Argentina: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Aesthetic 133
Table 135. Argentina: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by End User 134
Table 136. Rest of South and Central America: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Product 135
Table 137. Rest of South and Central America: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Application 136
Table 138. Rest of South and Central America: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Medical 136
Table 139. Rest of South and Central America: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by Aesthetic 137
Table 140. Rest of South and Central America: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) – by End User 137
Table 141. Recent Inorganic Growth Strategies in the Medical Ultrasound Flow Meter Market 139
Table 142. Recent Organic Growth Strategies in the Medical Ultrasound Flow Meter Market 139
Table 143. Glossary of Terms 173

Figure 1. Botulinum Toxin Market Segmentation, by Geography 27
Figure 2. PEST Analysis 32
Figure 3. Impact Analysis of Drivers and Restraints 36
Figure 4. Botulinum Toxin Market Revenue (US$ Million), 2023–2031 37
Figure 5. Global Botulinum Toxin Market, By Geography Forecast Analysis, 2023 & 2031 38
Figure 6. Botulinum Toxin Market Share (%) – by Product (2023 and 2031) 39
Figure 7. Botulinum Toxin A: Botulinum Toxin Market – Revenue and Forecast to 2031 (US$ Million) 40
Figure 8. Botulinum Toxin B: Botulinum Toxin Market – Revenue and Forecast to 2031 (US$ Million) 41
Figure 9. Botulinum Toxin Market Share (%) – by Application (2023 and 2031) 42
Figure 10. Medical: Botulinum Toxin Market – Revenue and Forecast to 2031 (US$ Million) 43
Figure 11. Aesthetic: Botulinum Toxin Market – Revenue and Forecast to 2031 (US$ Million) 44
Figure 12. Botulinum Toxin Market Share (%) – by End User (2023 and 2031) 46
Figure 13. Speciality and Dermatology Clinics: Botulinum Toxin Market – Revenue and Forecast to 2031 (US$ Million) 47
Figure 14. Hospitals and Clinics: Botulinum Toxin Market – Revenue and Forecast to 2031 (US$ Million) 48
Figure 15. Others: Botulinum Toxin Market – Revenue and Forecast to 2031 (US$ Million) 49
Figure 16. North America: Botulinum Toxin Market, by Key Country – Revenue (2023) (US$ Million) 50
Figure 17. North America: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) 51
Figure 18. North America: Botulinum Toxin Market Breakdown, by Key Countries, 2023 and 2031 (%) 54
Figure 19. United States: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) 55
Figure 20. Canada: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) 57
Figure 21. Mexico: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) 60
Figure 22. Europe: Botulinum Toxin Market, by Key Country – Revenue (2023) (US$ Million) 63
Figure 23. Europe: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) 64
Figure 24. Europe: Botulinum Toxin Market Breakdown, by Key Countries, 2023 and 2031 (%) 67
Figure 25. Germany: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) 68
Figure 26. United Kingdom: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) 71
Figure 27. France: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) 74
Figure 28. Italy: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) 77
Figure 29. Spain: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) 80
Figure 30. Rest of Europe: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) 83
Figure 31. Asia Pacific: Botulinum Toxin Market, by Key Country – Revenue (2023) (US$ Million) 86
Figure 32. Asia Pacific: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) 87
Figure 33. Asia Pacific: Botulinum Toxin Market Breakdown, by Key Countries, 2023 and 2031 (%) 90
Figure 34. Japan: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) 91
Figure 35. China: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) 94
Figure 36. India: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) 97
Figure 37. South Korea: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) 100
Figure 38. Australia: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) 103
Figure 39. Rest of APAC: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) 106
Figure 40. Middle East and Africa: Botulinum Toxin Market, by Key Country – Revenue (2023) (US$ Million) 109
Figure 41. Middle East and Africa: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) 110
Figure 42. Middle East and Africa: Botulinum Toxin Market Breakdown, by Key Countries, 2023 and 2031 (%) 112
Figure 43. Saudi Arabia: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) 113
Figure 44. United Arab Emirates: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) 116
Figure 45. South Africa: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) 119
Figure 46. Rest of Middle East and Africa: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) 122
Figure 47. South and Central America: Botulinum Toxin Market, by Key Country – Revenue (2023) (US$ Million) 125
Figure 48. South and Central America: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) 126
Figure 49. South and Central America: Botulinum Toxin Market Breakdown, by Key Countries, 2023 and 2031 (%) 128
Figure 50. Brazil: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) 129
Figure 51. Argentina: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) 132
Figure 52. Rest of South and Central America: Botulinum Toxin Market – Revenue and Forecast to 2031(US$ Million) 135
Figure 53. Growth Strategies in the Medical Ultrasound Flow Meter Market 138